Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
0913693 B.C. Ltd
Agios Pharmaceuticals, Inc. - Common Stock
Atico Mining Corp
Canada Nickel CO Inc
Captivision Inc. - Ordinary Shares
DPC Holdings PLC Ordinary Shares
Fnb Inc
Fujitsu Ltd
GCL Global Holdings Ltd - Warrants
Gold Terra Resource Corp
Kore Mining Ltd
Latin Metals Inc
Medbright AI Invts Inc
Midera Food Processing, Inc. - Common Stock
Monarch Cement CO
Open Lending Corporation - Common Stock
OptimumBank Holdings, Inc. - Common Stock
Pacer Solactive Whitney Future of Warfare ETF
Pmv Consumer Acquisition Corp
Potomac Bancshares Inc
Power REIT (MD) Common Stock
Prairie Operating Co. - Common Stock
Preferred Bank - Common Stock
ProAssurance Corporation Common Stock
Propel Holdings Inc
Rushnet Inc
Sci Engineered Mtrls Inc
SiTime Corporation - Common Stock
SigmaTron International, Inc. - Common Stock
Smart Card Marketing Systems Inc
Solid Biosciences Inc. - Common Stock
Sparta Comml Svcs Inc
Spectra7 Microsystems Inc
Star Gold Corp
Superior Group of Companies, Inc. - Common Stock
Tecogen Inc. - Common Stock
United Health Products Inc
Voyageur Pharmaceuticals Ltd
Wesdome Gold Mines Ltd
Yukon Metals Corp
iShares Future AI Beneficiaries ETF
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Beam Therapeutics
< Previous
1
2
3
Next >
Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
February 27, 2024
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05, 2024
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated Milestones
January 08, 2024
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
December 14, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference
November 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
November 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
October 31, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT
October 25, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline
October 19, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation
September 07, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 05, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in Upcoming September Investor Conferences
August 31, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
August 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in Upcoming May Investor Conferences
May 17, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
May 11, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
May 10, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
March 27, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer
March 21, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
March 15, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
March 01, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
February 28, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
February 07, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Progress Across Base Editing Portfolio and Outlines Key Anticipated Milestones
January 09, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Presents First In Vivo Proof of Concept Preclinical Data on Multiplex Base Edited ESCAPE Platform for Non-Genotoxic Conditioning Regimen for Patients with Sickle Cell Disease Ahead of Autologous Transplant
December 10, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022
December 02, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201
December 02, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the BofA Securities 2022 Virtual Biotech SMID Cap Conference
November 30, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease
November 14, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
